Antifungal And Antidepressant Drugs May Help Protect Against COVID-19 (Medicine)

New research published in the British Journal of Pharmacology indicates that two currently available medications–an antifungal drug and an antidepressant–can effectively inhibit the virus that causes COVID-19 in laboratory cells.

Investigators found that the antifungal itraconazole and the antidepressant fluoxetine each blocked the production of infectious SARS-CoV-2 virus in cell culture lab tests. When either drug was used in combination with the antiviral drug remdesiver, the combination showed synergistic effects and inhibited the production of SARS-CoV-2 by more than 90%.

“Preventive vaccination and therapeutic medicines against COVID-19 are both required to effectively combat pandemics caused by emerging zoonotic viruses such as SARS-CoV-2,” said senior author Ursula Rescher, PhD, of the University of Muenster, in Germany.


Reference: Schloer, S, Brunotte, L, Mecate‐Zambrano, A, et al. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro. Br J Pharmacol. 2021; 1– 12. https://doi.org/10.1111/bph.15418


Provided by Wiley

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s